Point Guard Biosciences Announces Innovation in Ophthalmology Award

News provided by

Point Guard Biosciences, LLC

27 Sep, 2016, 08:01 ET

TAMPA, Fla., Sept. 27, 2016 /PRNewswire/ -- Point Guard Biosciences, LLC (PGBio) announced today, that it is launching its second PGBio Innovation in Ophthalmology Award.  This award is created by PGBio to assist entrepreneurs in the area of ophthalmology with financial help as well as assistance with strategic planning.

"This award is focused on advancing innovative technologies currently in preclinical or early clinical stages of development that have application in critical areas of ophthalmology," says Barry Butler, CEO of Point Guard Biosciences. "Ideal projects for this award could include new drug delivery systems, novel pharmaceutical products, innovative medical devices, new diagnostic tools, or technology to improve clinical trials," he adds.

The award recipient will be chosen based on novelty of the medical research, and the ability of the project to improve the quality of life of patients. The winner will be awarded a cash prize of $10,000. In addition to the cash prize, the award recipient will receive assistance by the PGBio team with the development of a business plan.

The submission deadline for this award is January 20th 2017. The Award recipient will be announced on April 14th 2017.

For more information on how to apply, please visit our website: www.PointGuard.Bio

About Point Guard Biosciences
Point Guard Biosciences is devoted to finding, funding and developing innovative technologies in the areas of ophthalmic pharmaceuticals and medical devices.  The staff of PGBio has extensive experiences developing ophthalmic products, raising venture capital and managing start-up companies. 

PGBio is a member of the Point Guard Partners (PGP) Family of companies.  Other companies in the PGP family include Oculos Clinical Research, a full service ophthalmology-focused CRO and Oculos Consulting, which provides regulatory affairs and CMC consulting services to ophthalmic companies.

To learn more about all the companies in the PGP family, please visit our website: www.pointguardllc.com

Contact:  Rosa Corrales, Ph.D
[email protected] 

Logo - http://photos.prnewswire.com/prnh/20160926/411966LOGO

SOURCE Point Guard Biosciences, LLC

Related Links

http://www.pointguard.bio

PRN Top Stories Newsletters

Sign up to get PRN’s top stories and curated news delivered to your inbox weekly!

Thank you for subscribing!

By signing up you agree to receive content from us.
Our newsletters contain tracking pixels to help us deliver unique content based on each subscriber's engagement and interests. For more information on how we will use your data to ensure we send you relevant content please visit our PRN Consumer Newsletter Privacy Notice. You can withdraw your consent at any time in the footer of every email you'll receive. Mit Ihrer Anmeldung erklären Sie sich damit einverstanden, Inhalte von uns zu erhalten.
Unsere Newsletter enthalten Zählpixel, die die Lieferung einzigartiger Inhalte in Bezug auf das Abonnement und die Interessen der einzelnen Abonnenten ermöglichen. Weitere Informationen über die Verwendung Ihrer Daten im Hinblick auf die Zusendung von relevanten Inhalten, finden Sie in unserer PRN Consumer Newsletter Privacy Notice. Ihre Zustimmung können Sie jederzeit in der Fußzeile jeder erhaltenen E-Mail widerrufen. En vous inscrivant à la newsletter, vous consentez à la réception de contenus de notre part.
Notre newsletter contient des pixels espions nous permettant la fourniture à chaque abonné, d’un contenu unique en lien avec ses souscriptions et intérêts. Pour de plus amples informations sur l’utilisation faite de vos données en vue de l’envoi des contenus concernés, nous vous invitons à consulter la politique de confidentialité disponible à partir du lien suivant PRN Consumer Newsletter Privacy Notice. Vous pouvez à tout moment revenir sur votre consentement par le biais des informations situées au bas de chaque e-mail reçu. Регистрирайки се, Вие се съгласявате да получавате информационно съдържание от нас. Нашите бюлетини съдържат проследяващи пиксели, които ни помагат да предоставяме уникално съдържание въз основа на ангажираността и интересите на всеки абонат. За повече информация относно начина, по който ще използваме Вашите данни, за да гарантираме, че Ви изпращаме подходящо съдържание, моля, направете справка с нашето Уведомление за поверителност на потребителския бюлетин на PRN. Можете да оттеглите съгласието си по всяко време в долния колонтитул на всеки от имейлите, които ще получите.